Study design, recruitment, and eligibility
colon, biliary, or pancreatic cancer, fractures, GI cancer
ONCOLOGY, GI CANCER
This study was conducted on GI cancer patients receiving palliative chemotherapy to estimate the compliance, safety, and efficacy of an exercise intervention program (EIP). The clinical trial registration number is KCT 0005615 (CRIS, We aimed to recruit 30 patients to be able to estimate the compliance, safety, and efficacy of an EIP during palliative chemotherapy. Eligible participants were 19 years of age or older; diagnosed with recurrent or metastatic gastric, colon, biliary, or pancreatic cancer; had an Eastern Cooperative Oncology Group (ECOG) score between 0 and 1; a life expectancy of more than three months. Patients with decreased cognitive function, exercise restrictions, or fractures were excluded from this study. All participating patients provided written informed consent and permission from their physicians to participate.